作者
Moritz Platen,Maresa Buchholz,Anika Rädke,Fabian Kleinke,Annelie Scharf,Magdalena Pfaff,Arif Iskandar,Neeltje van den Berg,Wolfgang Hoffmann,Bernhard Michalowsky
摘要
Abstract Background Various comorbidity indices have been validated for individual health outcomes. However, systematic concurrent comparisons of multiple outcome measures in a single study remain relatively underrepresented but needed for practical decision support. Aims To compare the performance of the Charlson Comorbidity Index (CCI) and Rx-Risk Comorbidity Index (Rx-Risk). Methods Baseline and six-month follow-up data from n = 221 patients recruited in n = 70 practices were used. CCI and Rx-Risk scores were calculated using documented diagnoses and prescribed medications. Outcomes assessed were health-related quality of life (HRQoL, EQ-5D-5 L), functional impairment (B-ADL), cognitive decline (MMSE), and healthcare utilization (physician visits, hospitalizations). Indices performance was evaluated regarding agreement (Cohens Kappa (k)), known-groups validity (ANOVA, t-test), convergent validity (correlation coefficient (r s )) and predictive ability (R², Akaike information criterion (AIC)). Results Patients were, on average, 80 years old, mostly female (55%), with 12 diagnoses and seven medications. Agreement between both indices was poor for all conditions except diabetes (k = 0.645) and chronic airway diseases (k = 0.486). Rx-Risk differed more in known groups, especially for HRQoL and hospitalizations, and showed stronger correlations with the EQ-5D index (r s , -0.215 vs. -0.134) and risk of hospitalization (r s , 0.145 vs. 0.128) than CCI. Rx-Risk, again, performed better in predicting the change of EQ-5D index (R², 30 vs. 28%) and all EQ-5D dimensions, functional (R², 55 vs. 52%) and cognitive decline (R², 47 vs. 46%) and physician consultations (AIC, 649.2 vs. 651.0), except for hospitalization (AIC, 149.2 vs. 147.1). Conclusions Rx-Risk demonstrated slightly superior validity and predictive ability for HRQoL and healthcare utilization, making it a promising option for studies focused on these outcomes. However, limitations regarding functional and cognitive impairment suggest alternative instruments are needed.